and ejection systolic murmur (Beeson et al. 1979) .
The physiological hypervolaemia of pregnancy is generally beneficial to the disease. In contrast, hypovolaemia, hypotension, Valsalva manoeuvres, digitalis and trinitrin are dangerous and epidural anaesthesia is contraindicated. Oakley et al. (1979) concluded that pregnancy , is generally well tolerated by these patients. A short labour, antibiotic prophylaxis, an assisted delivery and oxytocics for the third stage are .recommended. This patient, despite causing grave concern, confirmed these recommendations. noticed sun intolerance in June 1981 (manifested by burning and itching) and in August she developed multiple milia on her face ( Figure I ). She had also noticed accelerated finger nail growth and increased growth of downy blonde vellous hair on her cheeks and backs of her fingers. Histopathological examination (Figure 2) confirmed the presence of milia. Full blood count, routine biochemistry, porphyrin' screen and antinuclear factor were all normal. Rheumatoid factor was weakly positive, with a Rose-Waaler titre of less than 1/8.
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Discussion
Benoxaprofen (Opren, Dista) is a non-steroidal, anti-inflammatory agent used for the relief of symptoms in osteoarthrosis and rheumatoid arthritis. Pharmacologically . it' has three important actions: (I) it regulates directional movement of monocytes in response to a stimulus; (2) it inhibits the enzyme Iipoxygenase which converts arachidonic acid to the leukotrienes; (3) it is a weak inhibitor of the enzyme cyclo-oxygenase, which converts arachidonic acid to prostaglandins. week. All were skin types I or II. Retesting after one week using irradiation monochromator showed that they all produced a flare between 310 and 330 nm at half the normal minimal erythema dose. There was no reaction between 330 and 360 nm. The action spectrum therefore appears to be between 310 and 330 nm. This coincides with the absorption spectrum of the drug. Similar studies have shown the major active wavelengths to be between 310 and 325 nm, but with activity at longer wavelengths in the UVA (Frain-Bell 1982) . The most severe reactions would therefore be expected from natural sunlight, but r~actions may also occur via window glass. Protection can be afforded by use of topical sunscreens with both UVA and UVB absorbing action. Susceptibility to photosensitivity is related to com~lexion: The population at greatest risk are the light-skinned types I and II individuals who do not tan well and burn easily.
Reversible onycholysis can be caused by benoxaprofen. Mikulaschek (1980) has e~timated an incidence of 8.7% out of 1681 patients on treatment. This is a gradual separation of the nail from the nail bed, beginning distally, usually involving no more than half the nail; complete shedding never occurs. The onycholysis usually affects the fingers but is also seen in toenails. Only about 12% of patients with onycholysis experience concomitant cutaneous I?hotosensitivity. This may be a photo-onycholysis, but ultraviolet light may not be the sole factor. We have seen several patients who report an accelerated nail growth whilst taking benoxaprofen associated with the onycholysis. Unlike that due to demethylchlortetracycline phototoxicity, the onycholysis seen with benoxaprofen is usually painless and frequently affects the thumbs and to a lesser extent the toes. If treatment is continued, 25% of patients will have spontaneous resolution of the onycholysis whilst on therapy. The remainder return to normal after stopping the drug.
In addition to increased nail growth, an accelerated hair growth has been noticed in some patients. We have reported 5 patients in wh0t? there has been hypertrichosis and increased hair and nail growth (Fenton et al. 1982) ; in 2 of these patients there was some reversal of male-pattern baldness. All but one of the patients had experienced cutaneous photosensitivity, and generally the hair was on sun-exposed sites.
The patient reported here, not only has hypertrichosis and accelerated nail growth, but also developed milia formation on sun-exposed areas. We have now seen 5 other patients on benoxaprofen who have developed milia affecting not only the face but also the scalp, neck, anterior chest, dorsum of hands and shoulders.
An abnormal reaction to sunlight is a well recognized side' effect in some patients taking benoxaprofen. In a review of 1681 patients taking benoxaprofen in the United States, Canada and Mexico, the incidence of cutaneous photosensitivity was found to be 9% (Mikulaschek 1980) . The more severe reactions seen were papular in nature, but most were described as a mild irritation manifested by burning, itching and erythema which disappeared several hours after sun exposure. It seldom interfered with therapy and only 0.7% found the irritation sufficient to discontinue benoxaprofen. Reactions were less frequent in patients with pronounced skin pigmentation. Recurrences could be prevented by using ultraviolet sunscreens.
The evidence until recently had been that the phototoxic reaction was due exclusively to UVAlongwave ultraviolet light (Kligman IQ81, unpublished) . However, we found that the action spectrum involves not only UVA but also UVBshortwave ultraviolet light (Fenton et at. 1981), and Kligman & Kaidbey (1982) have since agreed with this. Evaluation of the action spectrum by other workers has also confirmed this finding: Diffy & Hindson (1981, Stevens-Johnson syndrome has been reported in a 63-year-old woman who had been taking benoxaprofen 600 mg daily for 14 days. for osteoarthrosis (Taylor et al. 1981) . A similar but less convincing case was described by Morgan & Behn (1981) .
The most severe reaction to this drug that we have seen so far occurred in a 62-year-old woman with rheumatoid arthritis who developed toxic epidermal necrolysis, leukopenia and thrombocytopenic purpura after only 9 days treatment with benoxaprofen (Fenton & English 1982) .
There is an earlier report of transient neutropenia associated with benoxaprofen (Essigman & Williams 1980) , but in that case there were no cutaneous manifestations.
Although cutaneous reactions to benoxaprofen are common, they are usually mild and many patients continue on treatment, perhaps with the addition of a protective sunscreen through the Summer months. Milia, onycholysis, hypertrichosis and increased nail and hair growth are fully reversible on discontinuing benoxaprofen. The photosensitivity often responds to a decreased dosage or the use of a high protection factor or broad-spectrum sunscreen.
Addendum: Reports of serious side effects and deaths associated with the drug Opren led to its withdrawal from the UK market in August 1982.
